Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

Sponsor
Novo Nordisk A/S
Study ID
NCT01507337
Phase
PHASE1
Status
Completed

Conditions

  • Diabetes
  • Healthy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • liraglutide — DRUG
    A single dose of 1 mg administered subcutaneously (under the skin)

Study Details

This trial is conducted in Europe. The aim of this trial is to compare the exposure of liraglutide in young versus elderly healthy subjects.

Key Dates

Start date
Apr 30, 2004
Status verified
Jan 2017
Primary completion
Jun 30, 2004
Completion
Jun 30, 2004

Study Design

Enrollment
32 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Elderly
  • Experimental: Young

Primary Outcome Measure

Area under the liraglutide plasma concentration time curve (AUC 0-t)

Related Studies